← Back to Search

Decision Aid for Psoriatic Arthritis and Psoriasis (DA Trial)

N/A
Waitlist Available
Led By Alexis Ogdie-Beatty, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Initiation of a new psoriasis or psoriatic arthritis treatment
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights

DA Trial Summary

This trial will create and test a new way to help patients with psoriasis and/or psoriatic arthritis make decisions about their treatment.

Who is the study for?
This trial is for adults over 18 with psoriasis or psoriatic arthritis confirmed by a specialist, starting or switching to new FDA-approved treatments. It's only for patients treated at Penn clinics who can consent to participate.Check my eligibility
What is being tested?
The study aims to develop and evaluate a decision aid tool designed to help patients with psoriasis or psoriatic arthritis make informed choices about their treatment options in collaboration with their healthcare providers.See study design
What are the potential side effects?
Since the intervention is a decision aid tool rather than a medical treatment, there are no direct side effects associated with it. The focus is on improving the treatment decision-making process.

DA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am starting a new treatment for psoriasis or psoriatic arthritis.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with psoriasis or psoriatic arthritis by a specialist.

DA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient and provider self-reported perceptions of the decision aid as measured by satisfaction survey
Secondary outcome measures
Number of times decision aid was used in consultation for patients switching therapies or starting a new treatment.

DA Trial Design

1Treatment groups
Experimental Treatment
Group I: Decision Aid TestingExperimental Treatment1 Intervention
Participants will have the opportunity to test the different decision aid prototypes while selecting new treatment/therapy.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,988 Total Patients Enrolled
11 Trials studying Psoriasis
2,698 Patients Enrolled for Psoriasis
PfizerIndustry Sponsor
4,567 Previous Clinical Trials
10,911,773 Total Patients Enrolled
67 Trials studying Psoriasis
172,477 Patients Enrolled for Psoriasis
Alexis Ogdie-Beatty, MDPrincipal InvestigatorUniversity of Pennsylvania
3 Previous Clinical Trials
427 Total Patients Enrolled
1 Trials studying Psoriasis
40 Patients Enrolled for Psoriasis

Media Library

Decision Aid Testing Clinical Trial Eligibility Overview. Trial Name: NCT03737045 — N/A
Psoriasis Research Study Groups: Decision Aid Testing
Psoriasis Clinical Trial 2023: Decision Aid Testing Highlights & Side Effects. Trial Name: NCT03737045 — N/A
Decision Aid Testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT03737045 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Psoriatic Arthritis and Psoriasis Treatment Decision Aid
2018. "Psoriatic Arthritis and Psoriasis Treatment Decision Aid". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03737045.
All > Psoriasis > Plaque Psoriasis
~11 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top